EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recombinant SARS-CoV-2 Spike Protein Stimulates Secretion of Chymase, Tryptase, and IL-1β from Human Mast Cells, Augmented by IL-33

Irene Tsilioni, Theoharis C Theoharides iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24119487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Irene Tsilioni und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA. Hauptthemen laut MEDLINE: COVID-19, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anonymous donation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 infects cells via its spike (S) protein binding to its surface receptor angiotensin-converting enzyme 2 (ACE2) and results in the production of multiple proinflammatory cytokines, especially in the lungs, leading to what is known as COVID-19. However, the cell source and the mechanism of secretion of such cytokines have not been adequately characterized. In this study, we used human cultured mast cells that are plentiful in the lungs and showed that recombinant SARS-CoV-2 full-length S protein (1–10 ng/mL), but not its receptor-binding domain (RBD), stimulates the secretion of the proinflammatory cytokine interleukin-1β (IL-1β) as well as the proteolytic enzymes chymase and tryptase. The secretion of IL-1β, chymase, and tryptase is augmented by the co-administration of interleukin-33 (IL-33) (30 ng/mL). This effect is mediated via toll-like receptor 4 (TLR4) for IL-1β and via ACE2 for chymase and tryptase. These results provide evidence that the SARS-CoV-2 S protein contributes to inflammation by stimulating mast cells through different receptors and could lead to new targeted treatment approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Spike Glycoprotein, CoronavirusHumansAngiotensin-Converting Enzyme 2ChymasesCytokinesInterleukin-1betaInterleukin-33Mast CellsProtein BindingSARS-CoV-2Tryptases

Stichwörter der Autor:innen

ACE2coronaviruscytokinesinflammationmast cellsspike proteintoll-like receptors

Substanzen

Angiotensin-Converting Enzyme 2ChymasesCytokinesInterleukin-1betaInterleukin-33Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2TryptasesIL33 protein, humanCMA1 protein, human

Autor:innen und Institutionen

  • Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA.
  • Institute of Neuro-Immune Medicine, Nova Southeastern University, Clearwater, FL 33759, USA.

ORCID-Profile: Theoharis C Theoharides

Förderung

  • Anonymous donation

Zitieren

APA

Tsilioni, I., & Theoharides, T. C. (2023). Recombinant SARS-CoV-2 Spike Protein Stimulates Secretion of Chymase, Tryptase, and IL-1β from Human Mast Cells, Augmented by IL-33. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24119487

Vancouver

Tsilioni I, Theoharides TC. Recombinant SARS-CoV-2 Spike Protein Stimulates Secretion of Chymase, Tryptase, and IL-1β from Human Mast Cells, Augmented by IL-33. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24119487

BibTeX
@article{Tsilioni2023,
  author = {Tsilioni, Irene and Theoharides, Theoharis C},
  title = {Recombinant SARS-CoV-2 Spike Protein Stimulates Secretion of Chymase, Tryptase, and IL-1β from Human Mast Cells, Augmented by IL-33},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24119487}
}
Kostenlos starten →